Friday, 20 March 2026
  
Login

Australia's most trusted
source of pharma news

Friday, 20 March 2026
News

Companies ready to file new drugs

Posted 20 March 2026 AM

Six pharmas are readying to file either novel drugs or new indications for their therapies in Australia after scoring TGA pathways in the first two months of 2026.

Among the list are four new drugs, including BeOne Medicine’s bispecific HER2-directed antibody zanidatamab, which has scored an orphan drug designation for the treatment of biliary tract carcinoma and a provisional determination in oncology.

To see the whole article, please login

Popular

Novo slapped with Warning Letter
'Bad juju' crashes Aussie company
World's top drug, by a loophole
A-list attends Sanofi office opening
Latest Jobs
MORE NEWS
Email this article to a friend
From:

 
 
  
Print this article

Copyright Notice

Please click the button to indicate that the printout of this article is for your personal use only and not for any type of redistribution.

Redistribution of the whole or part of Pharma in Focus by any means is a breach of copyright law.

Welcome to Pharma in Focus

Please log in to read.

Hi

Our old access system is being retired.

Please create a password and click 'Log in' for ongoing access.

Hi

Please choose a password to secure your access to Pharma in Focus (minimum 8 characters).

Hi

You're here because you requested to reset your password.

Please choose a new password (minimum 8 characters).

To search the News Archive you need to be logged in.

 

You can choose not to do this now but after November 30, a password will be required.

To learn more about the new-look Pharma in Focus click here.


Subscribe
 
© 2003 - 2026 Lush Media | Privacy Statement | Subscribe to Pharma in Focus
home